Entasis Therapeutics Holdings Inc. Business Finance Contracts & Agreements
25 Contracts & Agreements
- Investor Rights Agreements (3 contracts)
- Note Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (7)
- Stock Agreements (4)
- Underwriting Agreements (1)
- Warrant Agreements (5)
- Amendment No. 1 to Investor Rights Agreement, dated as of May 23, 2022, by and between the Company and Parent (Filed With SEC on May 23, 2022)
- Registration Rights Agreement, dated February 18, 2022 by and between the Company and Innoviva (Filed With SEC on February 18, 2022)
- Securities Purchase Agreement, dated February 17, 2022, by and between the Company and Innoviva (Filed With SEC on February 18, 2022)
- Form of Warrant Certificate (Filed With SEC on February 18, 2022)
- Convertible Promissory Note, dated February 18, 2022 (Filed With SEC on February 18, 2022)
- Form of Registration Rights Agreement (Filed With SEC on May 3, 2021)
- Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva (Filed With SEC on May 3, 2021)
- Form of Warrant Certificate (Filed With SEC on May 3, 2021)
- Form of Restricted Stock Unit Grant Agreement (Filed With SEC on November 6, 2020)
- Form of Restricted Stock Unit Grant Notice (Time-Based) (Filed With SEC on November 6, 2020)
- Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)
- Securities Purchase Agreement, dated August 27, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)
- Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)
- Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)
- Form of Investor Rights Agreement (Filed With SEC on April 13, 2020)
- Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva (Filed With SEC on April 13, 2020)
- Form of Registration Rights Agreement (Filed With SEC on April 13, 2020)
- Form of Warrant Certificate (Filed With SEC on April 13, 2020)
- Common Stock Purchase Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
- Registration Rights Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
- 2018 Employee Stock Purchase Plan (Filed With SEC on November 14, 2018)
- Registration Rights Agreement, dated as of September 14, 2018 (Filed With SEC on September 18, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2018)